arginine has been researched along with pirenzepine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianconi, L; Capretti, L; Coiro, V; Davoli, C; Fagnoni, F; Gardini, E; Maffei, ML; Passeri, M; Speroni, G; Volpi, R | 1 |
| Arends, J; Wagner, ML; Willms, BL | 1 |
| Giordano, G; Pasquali, C; Ragazzi, E; Scandellari, C; Valentini, P; Zaccaria, M; Zeviani, M | 1 |
| Delitala, G; Frulio, T; Maioli, M; Pacifico, A | 1 |
| Arvat, E; Camanni, F; Deghenghi, R; Di Vito, L; Ghigo, E; Gianotti, L; Imbimbo, BP; Lenaerts, V | 1 |
| Bertaina, S; Bruno, G; Calderara, A; Camanni, F; Maccario, M; Martina, V; Pacchioni, M; Pontiroli, AE; Pozza, G; Tagliabue, M | 1 |
| Delbro, DS; Gustafsson, BI | 1 |
| Camanni, F; Ghigo, E; Grottoli, S; Maccario, M; Oleandri, SE; Procopio, M; Razzore, P | 1 |
| Müller, EE; Rolla, M | 1 |
| Boffano, GM; Camanni, F; Ghigo, E; Grottoli, S; Maccario, M; Oleandri, SE; Procopio, M; Savio, P | 1 |
| Coffa, FP; Kotecha, N | 1 |
| De Iuri, L; Imbrogno, S; Mazza, R; Tota, B | 1 |
| Hasui, Y; Ikeda, M; Tanabe, H | 1 |
1 review(s) available for arginine and pirenzepine
| Article | Year |
|---|---|
[Porphyria].
Topics: 5-Aminolevulinate Synthetase; Analgesics, Opioid; Antipsychotic Agents; Arginine; Benzodiazepines; Ferrochelatase; Haloperidol; Heme; Humans; Hydroxymethylbilane Synthase; Olanzapine; Pirenzepine; Plasma Exchange; Porphyria, Acute Intermittent; Prognosis | 2003 |
1 trial(s) available for arginine and pirenzepine
| Article | Year |
|---|---|
Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Adult; Arginine; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Growth Hormone; Humans; Male; Middle Aged; Pirenzepine | 1994 |
11 other study(ies) available for arginine and pirenzepine
| Article | Year |
|---|---|
Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects.
Topics: Adolescent; Adult; Arginine; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Exercise; Glucagon; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinetics; Muscarinic Antagonists; Pirenzepine; Receptors, Muscarinic | 1990 |
Cholinergic muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in type I diabetic subjects.
Topics: Adult; Arginine; Diabetes Mellitus, Type 1; Growth Hormone; Humans; Male; Middle Aged; Physical Exertion; Pirenzepine; Receptors, Muscarinic; Sweating | 1988 |
Effects of pirenzepine on plasma insulin, glucagon and pancreatic polypeptide levels in normal man.
Topics: Adult; Arginine; Benzodiazepinones; Blood Glucose; Glucagon; Glucose Tolerance Test; Humans; Insulin; Pancreatic Polypeptide; Pirenzepine; Radioimmunoassay; Time Factors | 1985 |
Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man.
Topics: Adult; Arginine; Benzodiazepinones; Glucagon; Growth Hormone; Humans; Male; Parasympatholytics; Pirenzepine; Prolactin; Receptors, Cholinergic; Receptors, Muscarinic | 1982 |
Modulation of growth hormone-releasing activity of hexarelin in man.
Topics: Adult; Amino Acid Sequence; Arginine; Evaluation Studies as Topic; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Molecular Sequence Data; Oligopeptides; Pirenzepine; Pyridostigmine Bromide; Somatostatin | 1995 |
Neurogenic inhibition of duodenal and jejunal motility in the anaesthetized rat.
Topics: Animals; Arginine; Duodenum; Gastrointestinal Motility; Jejunum; Male; Morphine; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Parasympatholytics; Piperidines; Pirenzepine; Rats; Rats, Sprague-Dawley; Sympatholytics; Vagotomy | 1994 |
In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
Topics: Adult; Arginine; Female; Glucose; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Muscarinic Antagonists; Obesity; Pirenzepine; Pituitary Gland, Anterior; Reference Values; Somatostatin | 1995 |
Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs.
Topics: Adolescent; Animals; Anorexia Nervosa; Arginine; Cholinergic Fibers; Dogs; Energy Intake; Female; Food Deprivation; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Muscarinic Antagonists; Neurosecretory Systems; Parasympathomimetics; Pirenzepine; Pyridostigmine Bromide; Receptors, Somatostatin | 1996 |
Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity.
Topics: Adult; Arginine; Blood Glucose; Female; Glucose Tolerance Test; Humans; Insulin; Parasympatholytics; Pirenzepine | 1997 |
NO mediates postjunctional inhibitory effect of neurogenic ACh in guinea pig small intestinal microcirculation.
Topics: Acetylcholine; Animals; Arginine; Arterioles; Electric Stimulation; Endothelium, Vascular; Enzyme Inhibitors; Female; Ganglia; Guinea Pigs; Intestine, Small; Iontophoresis; Male; Microcirculation; Nervous System; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Pirenzepine; Vasoconstriction | 1999 |
Nitric oxide modulates cardiac performance in the heart of Anguilla anguilla.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Anguilla; Animals; Arginine; Atropine; Detergents; Enzyme Inhibitors; Female; Free Radical Scavengers; Heart; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Molsidomine; Muscarinic Antagonists; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Octoxynol; omega-N-Methylarginine; Ornithine; Oxadiazoles; Parasympatholytics; Pirenzepine; Quinoxalines; Superoxide Dismutase | 2001 |